Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study's Locations section was updated to reflect new and reorganized site listings across the United States and Germany (including North Rhine-Westphalia). This change is accompanied by a page revision note: v3.3.3.SummaryDifference2%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe additions include a note that publications are automatically filled from PubMed and a new revision label (v3.3.2), while the older PubMed wording was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding status notice on the page has been removed, and all other content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedStudy details, eligibility criteria, outcomes, and locations appear unchanged between the two screenshots. No new or removed items affecting the main content are evident.SummaryDifference0.2%

- Check89 days agoChange DetectedAdded a government-operating-status notice and a v3.2.0 revision tag; removed the v3.1.0 tag. The overall meaning is that the page has updated to reflect current operating status and a new version.SummaryDifference3%

- Check97 days agoChange DetectedUpgrade noted: page revision updated from v3.0.2 to v3.1.0. No other substantive content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.